524752 Stock Overview
Decipher Labs Limited engages in the manufacture and trading of pharmaceutical drugs in India.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Decipher Labs Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹16.45 |
52 Week High | ₹25.75 |
52 Week Low | ₹14.50 |
Beta | 1.04 |
1 Month Change | 6.20% |
3 Month Change | -19.36% |
1 Year Change | -14.14% |
3 Year Change | -48.51% |
5 Year Change | -36.73% |
Change since IPO | -91.34% |
Recent News & Updates
Recent updates
Shareholder Returns
524752 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | 0.06% | -0.1% | 1.8% |
1Y | -14.1% | 55.9% | 46.4% |
Return vs Industry: 524752 underperformed the Indian Pharmaceuticals industry which returned 55.9% over the past year.
Return vs Market: 524752 underperformed the Indian Market which returned 46.4% over the past year.
Price Volatility
524752 volatility | |
---|---|
524752 Average Weekly Movement | 4.6% |
Pharmaceuticals Industry Average Movement | 6.0% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524752's share price has been volatile over the past 3 months.
Volatility Over Time: 524752's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1986 | 5 | Sushant Lal | decipherlabs.in |
Decipher Labs Limited engages in the manufacture and trading of pharmaceutical drugs in India. The company provides IT consultancy services, including technology integration and systems consulting, software development consulting, and management of IT projects. It also offers ERP implementation, mobile and cloud solutions, product development, and offshore services.
Decipher Labs Limited Fundamentals Summary
524752 fundamental statistics | |
---|---|
Market cap | ₹166.15m |
Earnings (TTM) | -₹49.11m |
Revenue (TTM) | ₹350.62m |
0.5x
P/S Ratio-3.4x
P/E RatioIs 524752 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
524752 income statement (TTM) | |
---|---|
Revenue | ₹350.62m |
Cost of Revenue | ₹1.48m |
Gross Profit | ₹349.14m |
Other Expenses | ₹398.26m |
Earnings | -₹49.11m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 30, 2024
Earnings per share (EPS) | -4.86 |
Gross Margin | 99.58% |
Net Profit Margin | -14.01% |
Debt/Equity Ratio | 0% |
How did 524752 perform over the long term?
See historical performance and comparison